Startups
immunitoAI is a TechBio company Unleashing the Full Potential of Antibody Therapeutics through our AI Platform AbInitio™.
Overview
Location
South Africa, Gauteng, Gosforth
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 6, 2023 | TechCrunch Disrupt 2023 Startup Battlefield 200: Health tech and sustainability | You’re just a couple weeks away from meeting the Startup Battlefield 200 companies in person at TechCrunch Disrupt 2023! We’re incredibly proud of — and impressed by — this year’s hand-picked cohort. To avoid utter overwhelm, we’re announci... |
| immunitoAI | “immunitoAI” |
Reviews 0
FAQ about immunitoAI
What has the press written about immunitoAI?
Parsers VC has collected 3 articles mentioning immunitoAI, among them “TechCrunch Disrupt 2023 Startup Battlefield 200: Health tech and sustainability” (Sep 6, 2023) and “immunitoAI”.
Is immunitoAI still active?
Yes, immunitoAI is active; its latest activity on Parsers VC dates from Aug 25, 2025.